tiprankstipranks
Newron Pharmaceuticals SpA (NWPHF)
OTHER OTC:NWPHF
US Market

Newron Pharmaceuticals SpA (NWPHF) Financial Statements

Compare
9 Followers

Newron Pharmaceuticals SpA Financial Overview

Newron Pharmaceuticals SpA's market cap is currently $176.20M. The company's EPS TTM is $-1.118; its P/E ratio is ―; Newron Pharmaceuticals SpA is scheduled to report earnings on March 18, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue€ 9.06M€ 6.09M€ 5.76M€ 5.26M€ 7.04M
Gross Profit€ 9.06M€ 6.09M€ 5.76M€ 4.96M€ 5.61M
Operating Income€ -11.63M€ -13.30M€ -12.36M€ -18.07M€ -20.90M
EBITDA€ -11.83M€ -13.32M€ -12.31M€ -17.99M€ -20.85M
Net Income€ -16.22M€ -17.49M€ -14.90M€ -21.00M€ -20.21M
Balance Sheet
Cash & Short-Term Investments€ 12.60M€ 22.77M€ 34.59M€ 31.25M€ 39.16M
Total Assets€ 25.87M€ 37.20M€ 50.49M€ 51.20M€ 60.29M
Total Debt€ 48.41M€ 45.66M€ 43.08M€ 26.34M€ 16.89M
Net Debt€ 42.08M€ 32.24M€ 18.06M€ 13.13M€ -5.17M
Total Liabilities€ 55.77M€ 51.23M€ 47.38M€ 33.95M€ 23.49M
Stockholders' Equity€ -29.91M€ -14.03M€ 3.11M€ 17.25M€ 36.80M
Cash Flow
Free Cash Flow€ -10.15M€ -11.11M€ -11.46M€ -15.62M€ -22.03M
Operating Cash Flow€ -10.14M€ -11.09M€ -11.45M€ -15.59M€ -21.98M
Investing Cash Flow€ 3.25M€ -317.00K€ 8.42M€ -616.00K€ -932.00K
Financing Cash Flow€ -192.00K€ -186.00K€ 14.83M€ 7.37M€ 17.34M
Currency in EUR

Newron Pharmaceuticals SpA Earnings and Revenue History

Newron Pharmaceuticals SpA Debt to Assets

Newron Pharmaceuticals SpA Cash Flow

Newron Pharmaceuticals SpA Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis